Poulam M. Patel

发表

Subcutaneous administration of recombinant glycosylated interleukin 6 in patients with cancer: pharmacokinetics, pharmacodynamics and immunomodulatory effects.

E. Ingham, J. Southgate, P. Selby, 2000, Cytokine.

Human Cells Pathway Regulates IL-23 Expression by The Ataxia Telangiectasia Mutated Kinase

C. Seedhouse, M. Refaee, A. Malecka, 2013 .

Human Cells Pathway Regulates IL-23 Expression by The Ataxia Telangiectasia Mutated Kinase

C. Seedhouse, M. Refaee, A. Malecka, 2013 .

Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: a randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group.

A. Eggermont, C. Punt, P. Patel, 2006, European journal of cancer.

The effect of combined expression of interleukin 2 and interleukin 4 on the tumorigenicity and treatment of B16F10 melanoma.

S. Humphreys, G. Mufti, F. Farzaneh, 1996, British Journal of Cancer.

Record-3: Phase II randomized trial comparing sequential first-line everolimus (EVE) and second-line sunitinib (SUN) versus first-line SUN and second-line EVE in patients with metastatic renal cell carcinoma (mRCC).

R. Motzer, K. Pittman, C. Barrios, 2013 .

Direct haplotype determination by double ARMS: specificity, sensitivity and genetic applications

Alexander F. Markham, P. Patel, Y. M. Lo, 1991, Nucleic Acids Res..

Prognostic value of serial blood S100B determinations in stage IIB-III melanoma patients: a corollary study to EORTC trial 18952.

A. Eggermont, V. Cocquyt, P. Patel, 2011, European journal of cancer.

Development and evaluation of human AP endonuclease inhibitors in melanoma and glioma cell lines

L. Dekker, C. Laughton, P. Fischer, 2011, British Journal of Cancer.

A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma

O. Nordle, S. Kilany, N. Connolly, 2007, British Journal of Cancer.

A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO).

T. Powles, F. Thistlethwaite, P. Patel, 2019, Journal of Clinical Oncology.

Ulceration of primary melanoma and responsiveness to adjuvant interferon therapy: Analysis of the adjuvant trials EORTC18952 and EORTC18991 in 2,644 patients.

A. Eggermont, A. Testori, P. Patel, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.